For the Inventor, By the Inventor

Enter assignee name

Shandong, China

Shandong Danhong Pharmaceutical Co., Ltd.

USPTO Granted Patents = 10

EPO Patents = 7

Forward Citations = 9

Loading Chart...

Loading Chart...

29 inventors (with patents filed for the assignee):

Haiying He (6 out of 60 patents)

Zhigan Jiang (5 out of 22 patents)

Weihua Shi (5 out of 13 patents)

4. Jian Li (4 out of 232 patents)

5. Shuhui Chen (4 out of 232 patents)

6. Wentao Wu (4 out of 31 patents)

7. Zhixiang Li (4 out of 13 patents)

8. Shuhui Chen (4 out of 130 patents)

9. Feng Xu (3 out of 27 patents)

10. Weidong Li (3 out of 16 patents)

11. Linghui Wu (3 out of 5 patents)

12. Hongwei Li (3 out of 35 patents)

13. Minggao Zeng (3 out of 4 patents)

14. Kunmin Lai (3 out of 4 patents)

15. Zheng Wang (3 out of 46 patents)

10 patents: Sort by Forward Citations

1. 12077513 - Process route of compound of formula (IV), crystal form and preparation method therefor (2024-09-03),

2. 11897830 - Crystal form and amorphous form of dezocine analogue hydrochloride (2024-02-13),

3. 11339119 - Crystal form and amorphous form of dezocine analogue hydrochloride (2022-05-24),

4. 10858322 - Process for preparing 1-isobutyryl-1'-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[D]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one (2020-12-08),

5. 10744109 - Sustained release suspension containing dezocine analogue ester and preparation method therefor (2020-08-18),

6. 10633347 - Crystal form B of 1-isobutyryl-1'-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[d]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one (2020-04-28),

7. 10414718 - Dezocine analogue (2019-09-17),

8. 10227309 - Crystal form A of 1-isobutyryl-1'-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo [d]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one (2019-03-12),

9. 10030029 - Imidazole derivative used as antiviral agent and use thereof in preparation of medicament (2018-07-24),

10. 9850251 - Imidazole derivative used as antiviral agent and use therof in preparation of medicament (2017-12-26),

Shandong Danhong Pharmaceutical Co., Ltd. is a leading pharmaceutical company specializing in the research, development, and production of traditional Chinese medicine. With a history dating back to 1999, the company has established a strong reputation for quality and innovation in the healthcare industry. Danhong Pharmaceutical is committed to improving the health and well-being of individuals through the creation of high-quality, effective medicines.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

10 Patents

#23 in Shandong

#2,772 in China

#55,879 in the World

Shandong, China

Shandong Danhong Pharmaceutical Co., Ltd.

Forward Citations = 9

29 inventors:

Haiying He (6 out of 60 patents)

Zhigan Jiang (5 out of 22 patents)

Weihua Shi (5 out of 13 patents)

4. Jian Li (4 out of 232 patents)

5. Shuhui Chen (4 out of 232 patents)

Please report any incorrect information to [email protected]

Loading…